BRIEF published on 07/09/2026 at 18:05, 3 hours 36 minutes ago THX Pharma annonce sa trésorerie en juin 2026. Étude De Phase 3 Maladie De Batten Maladie De Niemann-Pick THX Pharma Position De Trésorerie
BRIEF published on 07/09/2026 at 18:05, 3 hours 36 minutes ago THX Pharma maintains its financial stability as of June 30, 2026 Treasury Phase 3 TX01 THX Pharma Biocodex
BRIEF published on 07/09/2026 at 18:05, 3 hours 36 minutes ago THX Pharma Announces June 2026 Cash Position Cash Position Phase 3 Study Batten Disease Niemann-Pick Disease THX Pharma
BRIEF published on 07/09/2026 at 18:05, 3 hours 36 minutes ago THX Pharma maintient sa stabilité financière au 30 juin 2026 Trésorerie Phase 3 TX01 THX Pharma Biocodex
PRESS RELEASE published on 07/09/2026 at 18:00, 3 hours 41 minutes ago THX Pharma Reports Cash Position as of June 30, 2026 THX Pharma (Theranexus) announces cash position of €17.5 million as of June 30, 2026. Biocodex funds clinical development costs for Batten-1 program. Positive milestones achieved in 2026 towards commercialization Cash Position Commercialization THX Pharma Biocodex Batten-1 Program
PRESS RELEASE published on 07/09/2026 at 18:00, 3 hours 41 minutes ago THX Pharma publie sa position de trésorerie au 30 juin 2026 THX Pharma annonce sa trésorerie au 30 juin 2026 et les avancées majeures du premier semestre. Position financière solide pour la phase 3 de la maladie de Batten Trésorerie Position Financière Batten-1 Maladies Neurologiques Rares THX Pharma
BRIEF published on 06/23/2026 at 18:05, 16 days 3 hours ago THX Pharma nomme Sophie Jacq Lapointe à son conseil d'administration Conseil D'administration Maladies Rares Stratégie Pharmaceutique THX Pharma Sophie Jacq Lapointe
BRIEF published on 06/23/2026 at 18:05, 16 days 3 hours ago THX Pharma Appoints Sophie Jacq Lapointe to Board of Directors Board Of Directors Rare Diseases Pharmaceutical Strategy THX Pharma Sophie Jacq Lapointe
BRIEF published on 06/23/2026 at 18:05, 16 days 3 hours ago THX Pharma Accueille Sophie Jacq Lapointe dans son Conseil d'administration Conseil D'administration Stratégie Pharmaceutique THX Pharma Commercialisation Internationale Sophie Jacq Lapointe
BRIEF published on 06/23/2026 at 18:05, 16 days 3 hours ago THX Pharma Welcomes Sophie Jacq Lapointe to its Board of Directors Board Of Directors Pharmaceutical Strategy THX Pharma International Marketing Sophie Jacq Lapointe
Published on 07/09/2026 at 18:05, 3 hours 36 minutes ago Sky Gold Corp Reports on Gold and Multi-Element Results from Drilling at Evening Star, Nevada
Published on 07/09/2026 at 16:00, 5 hours 41 minutes ago Karbon-X Expands European Compliance Market Capabilities With Spanish EU ETS Registry Account
Published on 07/09/2026 at 14:00, 7 hours 41 minutes ago GameSquare Signs Dairy MAX as Brand Partner for the World of Dance
Published on 07/09/2026 at 19:25, 2 hours 16 minutes ago LIGHTON CHANGES ITS GOVERNANCE WITH THE APPOINTMENT OF JEAN-PHILIPPE BAERT AS CHIEF EXECUTIVE OFFICER AND MARIE DE LAUZON AS CHAIR OF THE BOARD OF DIRECTORS
Published on 07/09/2026 at 19:25, 2 hours 16 minutes ago LIGHTON FAIT ÉVOLUER SA GOUVERNANCE AVEC LA NOMINATION DE JEAN-PHILIPPE BAERT EN TANT QUE DIRECTEUR GÉNÉRAL ET DE MARIE DE LAUZON EN TANT QUE PRÉSIDENTE DU CONSEIL D’ADMINISTRATION
Published on 07/09/2026 at 18:46, 2 hours 54 minutes ago OHB publishes results of the subscription offer and announces completion of the capital increase
Published on 07/09/2026 at 18:05, 3 hours 36 minutes ago lePERMISLIBRE publie son chiffre d’affaires du premier semestre 2026
Published on 07/09/2026 at 18:48, 2 hours 52 minutes ago Information relative au nombre total des droits de vote et d’actions composant le capital social
Published on 07/09/2026 at 18:47, 2 hours 53 minutes ago ICADE - CP - Modification du contrat de liquidite au 01 juillet 2026
Published on 07/09/2026 at 18:39, 3 hours 2 minutes ago ICADE - CP - Bilan semestriel contrat de liquidité S1 2026
Published on 07/09/2026 at 18:00, 3 hours 41 minutes ago SMTPC - Communiqué sur le Chiffre d'affaires du 2ème trimestre 2026
Published on 07/09/2026 at 18:00, 3 hours 41 minutes ago Second-quarter 2026 activity: +7% (vs. Q2 2025)
